Capital Region Medical Center-Goldschmidt Cancer Center — Jefferson City, Missouri

Capital Region Medical Center-Goldschmidt Cancer Center is a clinical research site located in Jefferson City, Missouri, United States 65109.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Capital Region Medical Center-Goldschmidt Cancer Center has participated in 36 clinical trials with 4 currently active.

Therapeutic areas: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer.

Sponsors: Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Capital Region Medical Center-Goldschmidt Cancer Center?

Capital Region Medical Center-Goldschmidt Cancer Center has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Capital Region Medical Center-Goldschmidt Cancer Center conducted?

Capital Region Medical Center-Goldschmidt Cancer Center has 36 clinical trials on record, with 4 currently active. Their work covers Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer.

Is Capital Region Medical Center-Goldschmidt Cancer Center accredited by Crixeo Health?

Yes — Capital Region Medical Center-Goldschmidt Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Capital Region Medical Center-Goldschmidt Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.